11-117995596-C-T

Variant summary

Our verdict is Benign. Variant got -21 ACMG points: 0P and 21B. BP4_StrongBP6_Very_StrongBP7BS1BS2

The NM_001558.4(IL10RA):​c.696C>T​(p.Thr232Thr) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00362 in 1,614,152 control chromosomes in the GnomAD database, including 17 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★).

Frequency

Genomes: 𝑓 0.0027 ( 1 hom., cov: 32)
Exomes 𝑓: 0.0037 ( 16 hom. )

Consequence

IL10RA
NM_001558.4 synonymous

Scores

2

Clinical Significance

Benign/Likely benign criteria provided, multiple submitters, no conflicts B:7

Conservation

PhyloP100: -2.04
Variant links:
Genes affected
IL10RA (HGNC:5964): (interleukin 10 receptor subunit alpha) The protein encoded by this gene is a receptor for interleukin 10. This protein is structurally related to interferon receptors. It has been shown to mediate the immunosuppressive signal of interleukin 10, and thus inhibits the synthesis of proinflammatory cytokines. This receptor is reported to promote survival of progenitor myeloid cells through the insulin receptor substrate-2/PI 3-kinase/AKT pathway. Activation of this receptor leads to tyrosine phosphorylation of JAK1 and TYK2 kinases. Two transcript variants, one protein-coding and the other not protein-coding, have been found for this gene. [provided by RefSeq, Jan 2009]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Benign. Variant got -21 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.63).
BP6
Variant 11-117995596-C-T is Benign according to our data. Variant chr11-117995596-C-T is described in ClinVar as [Likely_benign]. Clinvar id is 302549.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr11-117995596-C-T is described in Lovd as [Likely_benign].
BP7
Synonymous conserved (PhyloP=-2.04 with no splicing effect.
BS1
Variant frequency is greater than expected in population amr. gnomad4 allele frequency = 0.00274 (418/152292) while in subpopulation AMR AF= 0.00595 (91/15296). AF 95% confidence interval is 0.00496. There are 1 homozygotes in gnomad4. There are 190 alleles in male gnomad4 subpopulation. Median coverage is 32. This position pass quality control queck.
BS2
High Homozygotes in GnomAdExome4 at 16 AR gene

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
IL10RANM_001558.4 linkc.696C>T p.Thr232Thr synonymous_variant Exon 6 of 7 ENST00000227752.8 NP_001549.2 Q13651

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
IL10RAENST00000227752.8 linkc.696C>T p.Thr232Thr synonymous_variant Exon 6 of 7 1 NM_001558.4 ENSP00000227752.4 Q13651

Frequencies

GnomAD3 genomes
AF:
0.00274
AC:
417
AN:
152174
Hom.:
1
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.000893
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00596
Gnomad ASJ
AF:
0.000576
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00270
Gnomad FIN
AF:
0.000847
Gnomad MID
AF:
0.00316
Gnomad NFE
AF:
0.00378
Gnomad OTH
AF:
0.00335
GnomAD3 exomes
AF:
0.00288
AC:
725
AN:
251462
Hom.:
4
AF XY:
0.00318
AC XY:
432
AN XY:
135904
show subpopulations
Gnomad AFR exome
AF:
0.000431
Gnomad AMR exome
AF:
0.00289
Gnomad ASJ exome
AF:
0.000992
Gnomad EAS exome
AF:
0.000163
Gnomad SAS exome
AF:
0.00585
Gnomad FIN exome
AF:
0.000647
Gnomad NFE exome
AF:
0.00345
Gnomad OTH exome
AF:
0.00326
GnomAD4 exome
AF:
0.00371
AC:
5427
AN:
1461860
Hom.:
16
Cov.:
31
AF XY:
0.00390
AC XY:
2833
AN XY:
727232
show subpopulations
Gnomad4 AFR exome
AF:
0.000687
Gnomad4 AMR exome
AF:
0.00356
Gnomad4 ASJ exome
AF:
0.000957
Gnomad4 EAS exome
AF:
0.000101
Gnomad4 SAS exome
AF:
0.00598
Gnomad4 FIN exome
AF:
0.000955
Gnomad4 NFE exome
AF:
0.00400
Gnomad4 OTH exome
AF:
0.00296
GnomAD4 genome
AF:
0.00274
AC:
418
AN:
152292
Hom.:
1
Cov.:
32
AF XY:
0.00255
AC XY:
190
AN XY:
74458
show subpopulations
Gnomad4 AFR
AF:
0.000890
Gnomad4 AMR
AF:
0.00595
Gnomad4 ASJ
AF:
0.000576
Gnomad4 EAS
AF:
0.00
Gnomad4 SAS
AF:
0.00291
Gnomad4 FIN
AF:
0.000847
Gnomad4 NFE
AF:
0.00378
Gnomad4 OTH
AF:
0.00331
Alfa
AF:
0.00349
Hom.:
5
Bravo
AF:
0.00337
Asia WGS
AF:
0.000866
AC:
3
AN:
3478
EpiCase
AF:
0.00360
EpiControl
AF:
0.00302

ClinVar

Significance: Benign/Likely benign
Submissions summary: Benign:7
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

Inflammatory bowel disease 28 Benign:4
Mar 16, 2015
Genome Diagnostics Laboratory, University Medical Center Utrecht
Significance: Likely benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing

- -

Jan 13, 2018
Illumina Laboratory Services, Illumina
Significance: Likely benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing

This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as likely benign is not then subjected to further curation. The score for this variant resulted in a classification of likely benign for this disease. -

Feb 03, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance: Benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing

- -

Jun 28, 2017
Clinical Genetics DNA and cytogenetics Diagnostics Lab, Erasmus MC, Erasmus Medical Center
Significance: Likely benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing

- -

not provided Benign:2
-
Breakthrough Genomics, Breakthrough Genomics
Significance: Likely benign
Review Status: criteria provided, single submitter
Collection Method: not provided

- -

Sep 01, 2024
CeGaT Center for Human Genetics Tuebingen
Significance: Likely benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing

IL10RA: BP4, BP7, BS2 -

not specified Benign:1
Aug 20, 2018
Eurofins Ntd Llc (ga)
Significance: Likely benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.63
CADD
Benign
5.5
DANN
Benign
0.54

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.020
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs4252311; hg19: chr11-117866311; COSMIC: COSV99922947; COSMIC: COSV99922947; API